ANA Awards Raymond D. Adams Lectureship to Dr. Eva Feldman
The American Neurological Association (ANA) honored Dr. Eva Feldman with the 2021 Raymond D. Adams Lectureship at their annual meeting.
The American Neurological Association (ANA) honored Dr. Eva Feldman with the 2021 Raymond D. Adams Lectureship at their annual meeting.
"I don't know of one person in Ann Arbor who has individually done more in the fight against ALS than (Dr.) Bob Schoeni." Dr. Eva Feldman remembers her friend, colleague and ALS ally in a moving letter.
A multidisciplinary group of University of Michigan researchers will investigate environmental exposures, chosen as one of the first projects in a new National Institutes of Health amyotrophic lateral sclerosis initiative.
Associate Professor Benjamin Murdock, Ph.D., speaks about the immune system and ALS on the podcast for the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium.
A CDC-funded multidisciplinary effort at U-M will investigate air pollution as a major and modifiable risk factor for ALS and seek to identify therapy targets.
In a recent publication, Dr. Brian Callaghan looks at how the approach of approving drug therapies differs between the United State and the United Kingdom.
The National ALS Registry, managed by the Center for Disease Control (CDC) is one of the most important weapons in the fight against Amyotrophic Lateral Sclerosis (ALS). At the Annual Surveillance Meeting, Pranger ALS Clinic Director Dr. Stephen Goutman presented an update of important findings funded by the CDC.
At the 31st Annual Meeting of NEURODIAB, Dr. Stephanie Eid was awarded the Angelika Bierhaus prize in basic research .
In honor of World Brain Day, established by the World Federation of Neurology, we wanted to share a selection of brain imaging from our research.
Speaking to the joint Harvard NeuroDiscovery Center and MassGeneral Institute for Neurodegenerative Disease Informatics group, Dr. Feldman discusses the problem of diabetic neuropathy, its causes and treatment, and our lab investigations of this condition.
Dr. Brian Callaghan shares his position about the current problems of diabetic neuropathy testing. He presented this argument during a debate at the American Diabetes Association's 81st Scientific Sessions.
Our collaborator in science Dr. Sunitha Nagrath shares her experiences and advice as a female engineer, from her beginnings in India to her work with us uncovering the secrets of exosomes.
Ever heard of a runner's high? The fourth installment of the NeuroNetwork for Emerging Therapies Mini Symposium Series explores the effects of exercise on the nervous system and brain health.
Funded by the NIDDK, CLARiFY is a multi-national collaborative grant that addresses the cognitive effects of Type 1 Diabetes. Along with our partners on the grant from Murdoch Children's Institute and Monash University (both in Australia), Dr. Eva Feldman discusses the problem and how we will will better understand this complication with a very
This marks the first time that Drs. Stephen Goutman and Benjamin Murdock have been awarded an R01 grant by the NIH.
What Causes ALS? National Registry Seeks Answer.
In honor of ALS Awareness Month, the American Neurological Association sat down with Dr. Eva Feldman, a past president of theirs, for a Q&A. Read it here.
Watch Dr. Eva Feldman join Internal Medicine Chair Dr. John Carethers and fellow NeuroNetwork for Emerging Therapies Faculty Drs. Rodica Pop-Busui and Salim Hayek for a webinar on post-COVID care, Long COVID and health disparities.
On World Voice Day, a message from a NeuroNetwork faculty member, Norman D. Hogikyan, M.D., FACS, Director of Michigan Medicine's Vocal Health Center.
Disease Models & Mechanisms selected Sarah Elzinga for a special Q&A about her recently published paper about the sex differences in insulin resistance, but not peripheral neuropathy in diet-induced prediabetes animal models